Search Results 191-200 of 13481 for Testosterone Cypionate

1. Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma - Mayo Clinic

   - Negative pregnancy test done =< 7 days prior to registration, for women of reproductive potential only NOTE: If the urine test is positive or cannot be ...

2. Crizotinib (oral route) - Mayo Clinic

   Your doctor will test for the presence of this gene. Crizotinib is also used to treat relapsed (cancer that has come back) or refractory (cancer that did ...

3. Ratio of 25(OH)D-to-24,25(OH)2D: A new test to confirm 24-hydroxylase (CYP24A1) deficiency as the cause of hypercalcemia - Mayo Clinic

   Researchers found that the ratio of 25(OH)D-to-24,25(OH)2D is necessary to estimate the calculation of vitamin D 24-hydroxylase enzyme activity to confirm ...

4. SYMPHONY: A Study Of Macitentan In Pulmonary Arterial Hypertension To Validate The PAH-SYMPACT - Mayo Clinic

   Has a negative serum pregnancy test at Screening and a negative urine pregnancy test at Baseline and agree to perform monthly urine pregnancy tests, and ...

5. Testing The Effects Of Oxybutynin For The Treatment Of Hot Flashes In Men Receiving Hormone Therapy For Prostate Cancer - Mayo Clinic

   Androgen deprivation therapy decreases testosterone and other androgens through medications or surgical removal of the testicles. Relative to placebo, low ...

6. Publications - Tomohiko Yamada, O.D. - Mayo Clinic

   Yamada T, Hatt SR, Leske DA, Moke PS, Parrucci NL, Reese JJ, Ruben JB, Holmes JM. A new computer-based pediatric vision-screening test. J AAPOS. 2015 Apr ...

7. Phase 3 Study Of DCC-2618 Vs Placebo In Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

   ... test at screening and a negative pregnancy test at Cycle 1 Day 1 prior to the first dose of study drug. Patients of reproductive potential must agree to ...

8. Technetium tc 99m carbon (inhalation route) - Side effects & uses - Mayo Clinic

   Before Using. In deciding to use a diagnostic test, any risks of the test must be weighed against the good it will do. This is a decision you and your doctor ...

9. Medical Research & Education - Mayo Clinic News Network

   Mayo Clinic and Stanford researchers develop first blood test to map tumor “neighborhoods,” improving prediction of therapy response. Brittany Cordeiro. May 6 ...

10. Ivosidenib, Nivolumab, And Ipilimumab Combination In Previously Treated Subjects With Nonresectable Or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    WOCBP who tested positive in a serum pregnancy test within 24 hours prior to the first day of IMP administration. ... Are taking known strong cytochrome P450 (CYP) ...